Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012968

EVP, Chief Medical Officer sold 1,186 shares at $14.83 ($17,590)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Sale : show line 1 in the form −1,186 $14.83 $17,590 51,791 D
Open-market sales · 1,186 sh · avg $14.83 · $17,590
Loading xslF345X03/doc4.xml…